Figure 11.
IPS and immunotherapy gene expression analysis. (a) The association between IPS and the immune related risk signature in CC patients. (b) The gene expression of PD1, CTLA4, PD-L1, and PD-L2 in low-risk and high- risk groups.
IPS and immunotherapy gene expression analysis. (a) The association between IPS and the immune related risk signature in CC patients. (b) The gene expression of PD1, CTLA4, PD-L1, and PD-L2 in low-risk and high- risk groups.